Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: A randomised, double-blind placebo-controlled trial

Tyndale, on behalf of the PGRN-PNAT Research Group

Research output: Contribution to journalArticlepeer-review

171 Scopus citations

Fingerprint

Dive into the research topics of 'Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: A randomised, double-blind placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences